SEP 4, 2026 · JOURNAL ARTICLE
Evaluation of clinical prognostic factors for radium-223 therapy in castration-resistant prostate cancer with bone metastases: the KYUCOG-1901 study
Scientific Reports
Single-centre observational cohort study with exploratory multivariable analyses of prognostic factors in a small sample; the authors acknowledge potential selection bias and call for prospective validation, placing this in hypothesis-generating territory rather than confirmatory evidence.
Reported
Sample size analysed93
Median follow-up25.2 months
SSE incidence28.0%